Dedicated biomedical start-up office at LSP

SPARK Impact has teamed up with Liverpool Science Park (LSP) to launch an office dedicated to start-up businesses in the biomedical sector. The office is the latest in a series of moves by LSP to position itself as a hotbed for technology start-ups based in Merseyside. Three companies have already signed up; Albert Medical Devices (AMD), a urology device business; Wesco Medical Holdings who produce nasogastric feeding tube devices; and Med ePad, a telemedical company.
All three have recently received Pathfinder and follow-on investments from The North West Fund for Biomedical, which is managed by SPARK Impact.
โ€œWe have invested in a range of companies with strong potential,โ€ said Dr Penny Attridge, senior investment director at SPARK Impact. โ€œOur latest idea for the biomedical cluster office is something SPARK Impact felt would be of great benefit to both the investee companies and Liverpool Science Park.โ€
Chris Musson, chief executive of LSP said: โ€œThe Park is already home to an array of knowledge-based companies from a huge variety of sectors and we are delighted to team up with SPARK Impact to launch the dedicated biomedical cluster office.โ€

Related Content

Pin It on Pinterest

Share This